Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
52-week range
$19.05 – $32.56
92% from low
Sector
Biotechnology
P/S (TTM)
6.7
EV / FCF (TTM)
15.6
Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders. Among its key offerings is Firdapse, an amifampridine phosphate tablet formulation approved for managing Lambert-Eaton Myasthenic Syndrome (LEMS). Catalyst also provides Ruzurgi, a specific treatment option for pediatric patients diagnosed with LEMS. Beyond its existing products, Catalyst is actively investigating additional applications for Firdapse, including its potential use in treating MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and hereditary neuropathy with liability to pressure palsies. The company engages in various strategic collaborations, such as licensing agreements with BioMarin Pharmaceutical Inc., and a joint development and commercialization agreement with Endo Ventures Limited concerning a generic version of Sabril tablets. Previously known as Catalyst Pharmaceutical Partners, Inc., the company adopted its current name in May 2015.
www.catalystpharma.comNo one on the platform currently holds CPRX.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 2,347,477 | $58.1M |
Auto-close: position no longer at broker (broker-quote-cache).
in FID 401k →No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 78.6% | 327.5% | — | — | — | |
| Rev. Growth % | 19.8% | 37.7% | ||||
| Profit Margin % | 36.4% | 30.9% | ||||
| Free Cash Flow Margin % | 35.4% | 39.2% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +1.7% on the P/E track.
At today's price, your expected annual return is +7.0% on the P/E track.
At today's price, your expected annual return is +11.3% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $635M | +9.7% | $1.95 | $1.83–$2.07 | 16.1× | 2 |
| 2027 | $718M | +13.0% | $2.41 | $2.11–$2.60 | 13.1× | 3 |
| 2028 | $792M | +10.3% | $2.58 | $2.51–$2.64 | 12.2× | 1 |
| 2029 | $877M | +10.8% | $2.73 | $2.66–$2.79 | 11.5× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-11 | $0.64 | $0.52 | -18.8% |
| 2026-02-25 | $0.42 | $0.42 | +0.0% |
| 2025-11-05 | $0.51 | $0.43 | -15.7% |
| 2025-08-06 | $0.58 | $0.43 | -25.9% |
| 2025-05-07 | $0.53 | $0.47 | -11.3% |
| 2025-02-26 | $0.32 | $0.47 | +46.9% |
| 2024-11-06 | $0.30 | $0.35 | +15.1% |
| 2024-08-07 | $0.23 |
| $0.33 |
| +44.7% |
| -0.54% |
| $12.3B |
| — |
| TLPHTalphera, Inc. | $1.16 | -0.85% | $60M | — |
| VKTXViking Therapeutics, Inc. | $28.99 | -1.26% | $3.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
$CPRX Should your next extra dollar go toward paying down your mortgage or building your investment portfolio? There is no universal answer—and the old advice to simply invest instead of paying off the house doesn't work for everyone. Your mortgage rate, cash reserves, retirement contributions, taxes, liquidity, and comfort with market risk can completely change the calculation. What makes sense with a 3% mortgage may look very different with a 7% loan. A 3% mortgage and a 7% mortgage are practically two different financial decisions. One may make keeping the debt and investing more attractive, while the other can make guaranteed interest savings increasingly difficult to ignore. The bigger question isn't “Mortgage or stocks?” It's: Where can your next dollar strengthen your financial position without leaving you vulnerable when life gets unpredictable? https://www.wizeinvesting.com/p/simple-steady-effective-building-with-500-a-month-in-lly
View on StockTwits ↗
$CPRX Thanks to everyone for all that professional comments. I was 14 years on that message board. My Investment is now in Santhera (SANN.SW), could be a next takeover (Owner of the Agamree Licence) . GLTA
View on StockTwits ↗
$CPRX @DLAT94 Anorher one I sold way too early. But the pick was good. Congrats longs!
View on StockTwits ↗
$CPRX we all were looking for this outcome. Been with this group for the better part of the last 10 years plus. I tank you all and I am super happy that many longs got to enjoy now the fruits of patience CPRX gave us. A good friend of mine worked at CPRX and introduced me to it when it was below $1. I can only thank him. So long all!
View on StockTwits ↗
$CPRX thank you cprx management I got in around $3 and never looked back. Wonderful company run beautifully we had many tough times and scary moments but you guys made it through and brought us here. I wish every investment could be as perfect as what you guys have done here. I will miss y’all. ❤️
View on StockTwits ↗
$CPRX ty CPRX I tried to look at this account on Robinhood yesterday and it was gone but I had money in my account. Try powder for crypto. Sad and happy at the same time
View on StockTwits ↗
$CPRX Now that the SEC today issued its official notice that Catalyst has been removed from the NASDAQ Exchange, I do not know how much longer this community will remain in existence here. So, I want to say that I will miss this group and the engaging posts that have occurred through the many years I have been a shareholder and participant here. I wish the very best to each and every one of you as shareholders and in your personal lives. It has been my pleasure to get to know many of you here and outside of this group. Take care everyone.
View on StockTwits ↗
$CPRX Well I guess this is it. Congrats longs I hope to see almost all of you in another stock. Where are you all putting your money these days? Best of luck to you all.
View on StockTwits ↗
SEI Stock Jumps 5% After-Hours As S&P 600 Inclusion Sparks Buying $SEI $CPRX https://stocktwits.com/news/equity/markets/sei-stock-jumps-after-hours-as-sandp-600-inclusions-sparks-buying/cZmAZYNR7Fc
View on StockTwits ↗
$CPRX / Angelini Pharma – Shareholder Vote $CPRX
View on StockTwits ↗
$CPRX this keeps heading higher and higher. Fuck I never got in at when it was sub 10 LOL I wished you boys good luck a few times over the last couple years and it keep going. Congrats , nice steady as she goes
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.